We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alpharma Predicts Impairment Charge for Generics Business
Alpharma Predicts Impairment Charge for Generics Business
March 8, 2005
In a decision prompted largely by difficult business conditions in the generics market, Alpharma is preparing to take a goodwill impairment charge on its U.S. generics business, the company said recently.